Phase 3 Systemic Lupus Erythematosus trials recruiting now

All Systemic Lupus Erythematosus trials, every phase

Other phases for Systemic Lupus Erythematosus

Phase 3 Systemic Lupus Erythematosus trials

• A Phase 3 Clinical Study of MIL62 in Systemic Lupus Erythematosus
  NCT07405970 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
  NCT06617325 · Phase: Phase 3 · Ages: 16 Years and older · Sex: All (male and female) · 242 locations
• A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
  NCT07430306 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 107 locations
• An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
  NCT05835310 · Phase: Phase 3 · Ages: 5 Years to 17 Years · Sex: All (male and female) · 100 locations
• Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
  NCT05799378 · Phase: Phase 3 · Ages: 55 Years and older · Sex: All (male and female) · 12 locations
• Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
  NCT06133972 · Phase: Phase 3 · Ages: 12 Years to 100 Years · Sex: All (male and female) · 143 locations
• Safety of Administering Isoniazid to SLE Patients to Prevent TB
  NCT06618573 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 55 Years · Sex: Female · 1 location
• Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia
  NCT07657793 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.